Sponsor
MabQuest Therapeutics S.A.
Avenue D'Ouchy 4, 1006
About the sponsor
MabQuest Therapeutics S.A. focuses on advanced cancer histologies in which immune checkpoint blockade is an established treatment option, with interest spanning tumour types such as metastatic melanoma, lung cancer, renal cell carcinoma, hepatocellular carcinoma, and gastric cancer.
- Metastatic melanoma
- Lung cancer
- Renal cell carcinoma
- Hepatocellular carcinoma
- Gastric cancer
The clinical programme also includes tumour settings defined by microsatellite instability-high status, reflecting interest in immunologically responsive cancers.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.